//]]>

Fibrinolytic Bacterial Enzymes with Thrombolytic Activity (Record no. 18105)

000 -LEADER
fixed length control field 02242nam a22004575i 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140310150243.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120102s2012 gw | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783642249808
978-3-642-24980-8
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number QR46
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.9041
Edition number 23
264 #1 -
-- Berlin, Heidelberg :
-- Springer Berlin Heidelberg,
-- 2012.
912 ## -
-- ZDB-2-SBL
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Kotb, Essam.
Relator term author.
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE
Title Fibrinolytic Bacterial Enzymes with Thrombolytic Activity
Medium [electronic resource] /
Statement of responsibility, etc by Essam Kotb.
300 ## - PHYSICAL DESCRIPTION
Extent XII, 74p. 15 illus., 6 illus. in color.
Other physical details online resource.
440 1# - SERIES STATEMENT/ADDED ENTRY--TITLE
Title SpringerBriefs in Microbiology
520 ## - SUMMARY, ETC.
Summary, etc Stress, high blood pressure, smoking, pollution, fast foods, overweight, excessive travelling, surgery, less movement are common features in our modern life. These features are risky for blood clotting disorders. According to WHO, over 29% of the total mortalities worldwide are due to thrombosis. By the year, 2020 cardiovascular diseases (CVDs) may cause an estimated 25 million deaths per year, thus antithrombotic therapy is of great interest. The available thrombolytic agents such as urokinase are highly expensive, antigenic, quite unspecific, pyretogenic and hemorrhagenic. Therefore, the production of fibrinolysing enzymes, which rapidly dissolute thrombi within the vascular tree, without the detriments by microorganisms, as described in this book, is the desirable aim of today’s research.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
Topical term or geographic name as entry element Human physiology.
Topical term or geographic name as entry element Microbiology.
Topical term or geographic name as entry element Cardiology.
Topical term or geographic name as entry element Hematology.
Topical term or geographic name as entry element Biomedicine.
Topical term or geographic name as entry element Medical Microbiology.
Topical term or geographic name as entry element Hematology.
Topical term or geographic name as entry element Cardiology.
Topical term or geographic name as entry element Human Physiology.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9783642249792
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-3-642-24980-8
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Item type E-Book
Copies
Price effective from Permanent location Date last seen Not for loan Date acquired Source of classification or shelving scheme Koha item type Damaged status Lost status Withdrawn status Current location Full call number
2014-04-05AUM Main Library2014-04-05 2014-04-05 E-Book   AUM Main Library616.9041